This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Choroquine and psychiatric complications

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Hydroxychloroquine and chloroquine are ssociated with psychiatric reactions, including reports of depression, anxiety, hallucinations, and psychosis (1)

Advice to patients (1):

  • advise patients taking hydroxychloroquine or chloroquine medicines to contact a doctor immediately if they experience new or worsening mental health problems (such as irrational thoughts, anxiety, hallucinations, and feeling confused or feeling depressed, including thoughts of self-harm or suicide)

  • family members or caregivers may also be advised to be vigilant for these reactions and the need to seek medical advice if they occur

Reference:

  • MRHA. Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions. Drug Safety Update volume 15, issue 7: February 2022: 2
  • Mubagwa K. Cardiac effects and toxicity of chloroquine: a short update. Int J Antimicrob Agents. 2020;56(2):106057. doi:10.1016/j.ijantimicag.2020.106057

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.